Searched for
USFDA FINAL NOD
Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...- Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod...
- Glenmark Pharma gets USFDA nod for diabetes management drug"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin h...
- Aurobindo Pharma gets USFDA nod for its expectorant tabletsThe company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture its generic Guaifenesin ...
- Aurobindo Pharma gets USFDA nod for infections treatment drugThe company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspen...
- Alembic Pharma surges 20% on USFDA nod for anti-depression drugBupropion Hydrochloride tablets USP have an estimated market size of $37 million.
- Zydus gets USFDA nod to market drugs for stomach ailments"Zydus Cadila has received the final approval from USFDA to market Omeprazole and Sodium bicarbonate capsules 20 mg/1100 mg (OTC)," the com...
- Aurobindo Pharma gets USFDA nod to market kidney ailment drugAurobindo Pharma has a total of 331 ANDA approvals (294 final nod, including 16 from Aurolife Pharma LLC and 37 tentative approvals) from t...
- Ajanta Pharma launches acid reflux drug in USThe approval from the United States Food and Drug Administration (USFDA) is for the capsules in the strengths of 20mg/1100 mg and 40 mg/110...
- Aurobindo Pharma gets USFDA nod for osteoporosis drug"The approved product has an estimated market size of USD 96 million for the twelve months ended January 2016 according to IMS," it said.
- Glenmark Pharma gets final USFDA nod for migraine drugQuoting IMS data, Glenmark said the approved product has an estimated market size of $87.8 million for the 12 months ended January 2016.
- Glenmark gets USFDA nod for contraceptive tabletsGlenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estrad...
- Glenmark gets USFDA nod for contraceptive tabletsApproval has been granted for generic version of Ortho Tri-cyclen Lo tablets of Janssen Pharmaceuticals, Inc.
- Glenmark gets tentative nod from USFDA for azelaic acid gelCiting IMS Health sales data, the company said the Finacea market achieved annual sales of approximately USD 128 million.
- Aurobindo Pharma receives USFDA nod for generic drugThe company's product is generic version of Duramed Pharmaceuticals Aygestin tablets in the same strength, Aurobindo Pharma said.
- Glenmark gets USFDA final nod for anti-bacterial drug ZyvoxThe product is the therapeutic equivalent of Zyvox tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer, it added.
- Aurobindo gets USFDA nod to market generic Osteoporosis drugThe company has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Risedronate Sodium tablets, Au...
- Aurobindo Pharma gets USFDA final nod for generic anti-epileptic drugAurobindo Pharma has received final nod from the US health regulator to make and market generic anti-epileptic Phenytoin Sodium capsules in...
- Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
- Aurobindo Pharma surges 13% on USFDA nodShares of Aurobindo Pharma extended gains after the company received US administration's approval for Sertraline Hydrochloride oral concent...
Load More
